Could we design the RCT as a non-inferiority trial at this situation? [Design Issues]

posted by dennis001 – Hong Kong, 2022-07-27 07:21 (630 d 10:42 ago) – Posting: # 23181
Views: 2,118

Dear ElMaestro

❝ Clearly a case for an NI trial one way or another.

Thank you for your comment that helped to assuage my doubts.

❝ Clearly a case for a scientific advice where you need the authority's nod for margin and design before you kick off.

Ok. we will discuss with them.

Complete thread:

UA Flag
 Admin contact
22,985 posts in 4,823 threads, 1,653 registered users;
43 visitors (0 registered, 43 guests [including 10 identified bots]).
Forum time: 18:04 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz